360° SearchNetwork Hot Spots Trends Time Series

Publication: Lancet Infectious Diseases

First reported May 23 2013 - Updated May 23 2013 - 1 reports

[Articles] Soil-transmitted helminth infection in South America: a systematic review and geostatistical meta-analysis

Our findings offer important baseline support for spatial targeting of soil-transmitted helminthiasis control, and suggest that more information about the prevalence of soil-transmitted helminth infection is needed, especially in countries in which we ... [Published Lancet Infectious Diseases - May 23 2013]

Entities: Infection, Helminthiasis

First reported May 23 2013 - Updated May 23 2013 - 1 reports

[Review] Rapid diagnostic tests for neurological infections in central Africa

Infections are a leading cause of life-threatening neuropathology worldwide. In central African countries affected by endemic diseases such as human African trypanosomiasis, tuberculosis, HIV/AIDS, and schistosomiasis, delayed diagnosis and treatment ... [Published Lancet Infectious Diseases - May 23 2013]

Entities: infections, Diagnostic, African Trypanosomiasis, Sequela

First reported May 23 2013 - Updated May 23 2013 - 1 reports

[Series] Drug-resistant tuberculosis: time for visionary political leadership

Two decades ago, WHO declared tuberculosis a global emergency, and invested in the highly cost-effective directly observed treatment short-course programme to control the epidemic. At that time, most strains of Mycobacterium tuberculosis were susceptible ... [Published Lancet Infectious Diseases - May 23 2013]

Entities: Tuberculosis, Visionary, Leadership, Mycobacterium Tuberculosis

First reported May 23 2013 - Updated May 23 2013 - 1 reports

[Articles] Delayed versus immediate treatment for patients with acute hepatitis C: a randomised controlled non-inferiority trial

Delayed treatment is effective although not of equal efficacy to immediate treatment; coupled with the rate of spontaneous clearance it can reduce unnecessary treatment in closely monitored populations. Immediate treatment seems preferable in populations ... [Published Lancet Infectious Diseases - May 23 2013]

Entities: Hepatitis C, Patient

First reported May 23 2013 - Updated May 23 2013 - 1 reports

[Series] Engaging communities in tuberculosis research

According to a growing consensus among biomedical researchers, community engagement can improve the ethics and outcomes of clinical trials. Although successful efforts to develop community engagement practices in HIV/AIDS research have been reported, ... [Published Lancet Infectious Diseases - May 23 2013]

Entities: Tuberculosis, AIDS Research, Clinical trials

First reported May 23 2013 - Updated May 23 2013 - 2 reports

[Articles] AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial

AS03-adjuvanted TIV has a higher efficacy for prevention of some subtypes of influenza than does a non-adjuvanted TIV. Future influenza vaccine studies in elderly people should be based on subtype or lineage-specific endpoints. ... [Published Lancet Infectious Diseases - May 23 2013]

Entities: Inactivation, Influenza, Phase III

First reported May 23 2013 - Updated May 23 2013 - 1 reports

[Correspondence] Pretreatment HIV-1 drug resistance in Africa

We recently showed that pretreatment antiretroviral resistance more than doubled the risk of virological failure and further acquisition of drug-resistance mutations in patients receiving standard first-line antiretroviral therapy (ART) from a large sub-Saharan ... [Published Lancet Infectious Diseases - May 23 2013]

Entities: Pretreatment, antiretroviral therapy, Antiretroviral Drugs, mutations

First reported May 23 2013 - Updated May 23 2013 - 1 reports

[Media Watch] The unfinished history of tuberculosis

Spitting Blood: The History of Tuberculosis begins with George Orwell. The writer of 1984 “drowned in his own blood after a severe lung haemorrhage on 21 January 1950”. Author Helen Bynum contends that “Orwell died on the cusp of a new, more positive ... [Published Lancet Infectious Diseases - May 23 2013]

Entities: Tuberculosis, George Orwell, Isoniazid

First reported May 23 2013 - Updated May 23 2013 - 1 reports

[Newsdesk] Challenges and targets for measles elimination

As evidence mounts that the elimination of measles is faltering, looks at the scale of the problem worldwide, and what is being done to fight back against the disease. ... [Published Lancet Infectious Diseases - May 23 2013]

First reported May 23 2013 - Updated May 23 2013 - 1 reports

[Newsdesk] Highlights from the 23rd ECCMID

Clinical microbiologists and infectious diseases experts from across Europe and further afield gathered in Berlin, April 27–30. Peter Hayward reports from a conference dominated by resistance. ... [Published Lancet Infectious Diseases - May 23 2013]

Entities: Peter Hayward, Microbiologist, Infectious Diseases

First reported May 23 2013 - Updated May 23 2013 - 1 reports

[Newsdesk] The world waits for H7N9 to yield up its secrets

As the number of cases and deaths caused by influenza A H7N9 in China continue to rise, takes a look at some of the key gaps in our knowledge. ... [Published Lancet Infectious Diseases - May 23 2013]

Entities: H7N9, Influenza, China

First reported May 23 2013 - Updated May 23 2013 - 1 reports

[Comment] Acute hepatitis C: to treat or not to treat

Individuals recently infected with the hepatitis C virus are regarded as having acute disease. When such an infection lasts more than 6 months, the disease is considered chronic. This distinction, although arbitrary, was chosen because most patients who ... [Published Lancet Infectious Diseases - May 23 2013]

Entities: Hepatitis C, Patient, Infection, hepatocellular carcinoma

More Content

sort by: Date \| Relevance
[Review] Rapid diagnostic tests for neurologica... [Published Lancet Infectious Diseases - May 23 2013]
[Series] Engaging communities in tuberculosis r... [Published Lancet Infectious Diseases - May 23 2013]
[Series] Drug-resistant tuberculosis: time for ... [Published Lancet Infectious Diseases - May 23 2013]
[Articles] Soil-transmitted helminth infection ... [Published Lancet Infectious Diseases - May 23 2013]
[Articles] Delayed versus immediate treatment f... [Published Lancet Infectious Diseases - May 23 2013]
[Articles] AS03-adjuvanted versus non-adjuvante... [Published Lancet Infectious Diseases - May 23 2013]
[Media Watch] The unfinished history of tubercu... [Published Lancet Infectious Diseases - May 23 2013]
[Newsdesk] Challenges and targets for measles e... [Published Lancet Infectious Diseases - May 23 2013]
[Newsdesk] Highlights from the 23rd ECCMID [Published Lancet Infectious Diseases - May 23 2013]
[Newsdesk] The world waits for H7N9 to yield up... [Published Lancet Infectious Diseases - May 23 2013]
[Correspondence] Pretreatment HIV-1 drug resist... [Published Lancet Infectious Diseases - May 23 2013]
[Correspondence] Congenital neurosyphilis – Aut... [Published Lancet Infectious Diseases - May 23 2013]
[Correspondence] Congenital neurosyphilis [Published Lancet Infectious Diseases - May 23 2013]
[Comment] HIV epidemic in men who have sex with... [Published Lancet Infectious Diseases - May 23 2013]
[Comment] The end of the road for empirical ant... [Published Lancet Infectious Diseases - May 23 2013]
[Comment] Landscape of neglected tropical disea... [Published Lancet Infectious Diseases - May 23 2013]
[Comment] Acute hepatitis C: to treat or not to... [Published Lancet Infectious Diseases - May 23 2013]
[Comment] AS03-adjuvanted influenza vaccine in ... [Published Lancet Infectious Diseases - May 23 2013]
[Editorial] A proportionate response to H7N9 [Published Lancet Infectious Diseases - May 23 2013]